Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 157Sarcoma 7Gastrointestinal 5Breast 4Genitourinary 3Thoracic 2Lymphoid 2Plasma cell 1Other solid neoplasm 1Other hematologic neoplasm 1Head & Neck 1Gynecologic 1Dermatologic 1Classical hematology 1

Conditions

Neoplasms 23Venous Thromboembolism 20Febrile Neutropenia 20Anemia 19Thrombocytopenia 14Myelodysplastic Syndromes 14Leukemia, Myeloid, Acute 14Lymphoma 12Leukemia 12Anemia, Refractory, with Excess of Blasts 10Anemia, Aplastic 10Colorectal Neoplasms 9Breast Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Anemia, Sickle Cell 7Anemia, Iron-Deficiency 7Neutropenia 6Multiple Myeloma 6Ovarian Neoplasms 5Neoplasms, Plasma Cell 5Lymphoma, Follicular 5Hematologic Neoplasms 5Fanconi Anemia, Complementation Group D1 5Hemophilia A 4Chemotherapy-induced Thrombocytopenia 4Stroke 3Pulmonary Disease, Chronic Obstructive 3Parkinson Disease 3Osteoporosis 3Multiple Sclerosis 3

Interventions

Rivaroxaban 1Long-Term Synaptic Depression 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Glioma × Classical hematology × Clear all
NCT06196918 2024-01-09

Efficacy and Safety of Rivaroxaban in the Prevention of Venous Thromboembolism in Glioma Patients

Nanfang Hospital, Southern Medical University

Phase NA Unknown
320 enrolled
CNSClassical hematology

Glioma, Dyskinesias, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡